tiprankstipranks
Trending News
More News >
Palisade Bio (PALI)
NASDAQ:PALI
US Market

Palisade Bio (PALI) Financial Statements

Compare
640 Followers

Palisade Bio Financial Overview

Palisade Bio's market cap is currently $247.35M. The company's EPS TTM is $; its P/E ratio is -0.39; Palisade Bio is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 250.00K$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 250.00K$ 0.00$ 0.00$ -146.00K
Operating Income$ -14.86M$ -13.07M$ -15.72M$ -41.85M$ -9.30M
EBITDA$ -14.42M$ -12.28M$ -14.24M$ -24.22M$ -9.94M
Net Income$ -14.44M$ -12.30M$ -14.26M$ -26.62M$ -10.32M
Balance Sheet
Cash & Short-Term Investments$ 9.82M$ 12.43M$ 12.38M$ 10.49M$ 729.00K
Total Assets$ 10.88M$ 14.05M$ 15.76M$ 12.51M$ 3.02M
Total Debt$ 169.00K$ 369.00K$ 404.00K$ 199.00K$ 1.42M
Net Debt$ -9.65M$ -12.06M$ -11.98M$ -10.30M$ 708.00K
Total Liabilities$ 3.39M$ 2.74M$ 3.28M$ 5.15M$ 10.12M
Stockholders' Equity$ 7.49M$ 11.31M$ 12.48M$ 7.37M$ -7.10M
Cash Flow
Free Cash Flow$ -12.19M$ -11.14M$ -13.37M$ -14.77M$ -4.77M
Operating Cash Flow$ -12.19M$ -11.13M$ -13.36M$ -14.77M$ -4.77M
Investing Cash Flow$ 0.00$ -4.00K$ -10.00K$ -54.00K$ -6.00K
Financing Cash Flow$ 9.58M$ 11.19M$ 15.26M$ 24.61M$ 1.89M
Currency in USD

Palisade Bio Earnings and Revenue History

Palisade Bio Debt to Assets

Palisade Bio Cash Flow

Palisade Bio Forecast EPS vs Actual EPS